drugset / Trial / NCT02349243

Effect of Entacapone on Bodyweight Loss in Obese Population

NCT02349243

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, controlled, double blind clinical trial. The purpose of this study is to investigate the weight loss efficacy of entacapone. In this study, participants are randomly divided into entacapone and placebo groups. The percentage change in body weight, the body mass index, waist circumstance, extent of fatty liver, quantity of visceral fat, serum insulin, serum triglyceride and the adverse effects are compared between the two groups.

Timeline

Start
2015-01
Primary completion
2015-09
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Entacapone Small molecule 200 mg Oral

Indications